Ko T - Search Results

1

Aberrant ENaC activation in Dahl salt-sensitive rats.

Kakizoe Y, Kitamura K, Ko T, Wakida N, Maekawa A, Miyoshi T, Shiraishi N, Adachi M, Zhang Z, Masilamani S, Tomita K. Kakizoe Y, et al. Among authors: ko t. J Hypertens. 2009 Aug;27(8):1679-89. doi: 10.1097/HJH.0b013e32832c7d23. J Hypertens. 2009. PMID: 19458538

2

Inhibition of prostasin-induced ENaC activities by PN-1 and regulation of PN-1 expression by TGF-beta1 and aldosterone.

Wakida N, Kitamura K, Tuyen DG, Maekawa A, Miyoshi T, Adachi M, Shiraishi N, Ko T, Ha V, Nonoguchi H, Tomita K. Wakida N, et al. Among authors: ko t. Kidney Int. 2006 Oct;70(8):1432-8. doi: 10.1038/sj.ki.5001787. Epub 2006 Aug 30. Kidney Int. 2006. PMID: 16941024 Free article.

3

Camostat mesilate inhibits prostasin activity and reduces blood pressure and renal injury in salt-sensitive hypertension.

Maekawa A, Kakizoe Y, Miyoshi T, Wakida N, Ko T, Shiraishi N, Adachi M, Tomita K, Kitamura K. Maekawa A, et al. Among authors: ko t. J Hypertens. 2009 Jan;27(1):181-9. doi: 10.1097/hjh.0b013e328317a762. J Hypertens. 2009. PMID: 19145783

4

[Catecholamine, three fractions of catecholamines, three fractions of free catecholamines].

Ko T, Tomita K. Ko T, et al. Nihon Rinsho. 2005 Aug;63 Suppl 8:376-9. Nihon Rinsho. 2005. PMID: 16149533 Review. Japanese. No abstract available.

5

Regulation of adrenal aldosterone production by serine protease prostasin.

Ko T, Kakizoe Y, Wakida N, Hayata M, Uchimura K, Shiraishi N, Miyoshi T, Adachi M, Aritomi S, Konda T, Tomita K, Kitamura K. Ko T, et al. J Biomed Biotechnol. 2010;2010:793843. doi: 10.1155/2010/793843. Epub 2010 Mar 2. J Biomed Biotechnol. 2010. PMID: 20204133 Free PMC article.

6

[Catecholamine, three fractions of catecholamines, three fractions of free catecholamines].

Ko T, Tomita K. Ko T, et al. Nihon Rinsho. 2010 Jul;68 Suppl 7:404-7. Nihon Rinsho. 2010. PMID: 20960804 Japanese. No abstract available.

7

Effect of intravenous iron administration frequency on AOPP and inflammatory biomarkers in chronic hemodialysis patients: a pilot study.

Anraku M, Kitamura K, Shintomo R, Takeuchi K, Ikeda H, Nagano J, Ko T, Mera K, Tomita K, Otagiri M. Anraku M, et al. Among authors: ko t. Clin Biochem. 2008 Oct;41(14-15):1168-74. doi: 10.1016/j.clinbiochem.2008.07.007. Epub 2008 Jul 28. Clin Biochem. 2008. PMID: 18692036 Clinical Trial.

8

Functionalized MXene ink enables environmentally stable printed electronics.

Ko TY, Ye H, Murali G, Lee SY, Park YH, Lee J, Lee J, Yun DJ, Gogotsi Y, Kim SJ, Kim SH, Jeong YJ, Park SJ, In I. Ko TY, et al. Nat Commun. 2024 Apr 24;15(1):3459. doi: 10.1038/s41467-024-47700-y. Nat Commun. 2024. PMID: 38658566

9

Structural insights into the molecular mechanism of phytoplasma immunodominant membrane protein.

Liu CY, Cheng HP, Lin CP, Liao YT, Ko TP, Lin SJ, Lin SS, Wang HC. Liu CY, et al. Among authors: ko tp. IUCrJ. 2024 May 1. doi: 10.1107/S2052252524003075. Online ahead of print. IUCrJ. 2024. PMID: 38656311

10

Psychological Aspects of Facial Palsy.

Shamil E, Noriega M, Moin S, Ko TK, Tan DJY, Meller C, Andrews P, Lekakis G. Shamil E, et al. Among authors: ko tk. Facial Plast Surg. 2024 Apr 22. doi: 10.1055/s-0044-1782678. Online ahead of print. Facial Plast Surg. 2024. PMID: 38648794

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,352 results

Search Page